Two Way Bioequivalence Study Under Fed Conditions

Inclusion Criteria: * provide written informed consent. * healthy adult within 18-45 years of age (inclusive). * Body mass index of ≥ 18.5 kg/m2 and ≤ 25 kg/m2, with body weight not less than 50 kg. * systolic blood pressure with upper limit of less than 140 mmHg and lower limit of more than or equal to 90 mm Hg. * normal health as determined by medical history and physical examination performed within 15 days prior to the dosing of period 1. * Normal ECG, chest X-ray and vital signs. * If study volunteer is a female and is of child bearing potential practicing an acceptable method of birth control for the duration of the study. Exclusion Criteria: * The study participants were excluded based on the following criteria: * incapable of understanding the informed consent. * history of hypersensitivity or idiosyncratic reaction to study drug or any other related drug. * evidence of impairment of renal, hepatic, cardiac, lung or gastrointestinal function * volunteers with a history of tuberculosis, epilepsy, asthma (during past 5 years), diabetes, psychosis or glaucoma . * smokes regularly more than ten cigarettes daily * taken over the counter or prescribed medications * history of any psychiatric illness, which may impair the ability to provide written, informed consent or full participation. * history of alcohol or substance abuse within the last 5 years. * clinically significant abnormal values of laboratory parameters. * positive urine screen for drugs of abuse at the time of admission check-in for each period.